| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |